Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biora Therapeutics Q2 2024 GAAP EPS $(0.04) Beats $(0.45) Estimate, Sales $318.000K Up From $2.000K YoY

Author: Benzinga Newsdesk | August 12, 2024 04:38pm
Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.45) by 91.11 percent. This is a 97.28 percent increase over losses of $(1.47) per share from the same period last year. The company reported $318.000 thousand in sales this quarter. This is a 15.80K percent increase over sales of $2.000 thousand the same period last year.

Posted In: BIOR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist